Allergan Inc (AGN)

AGN (NYSE:Drugs) EQUITY
$232.40
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AGN Avg Daily Volume: 2,195,500
Last Update: 02/26/15 - 4:00 PM EST
Volume: 0
YTD Performance: 9.32%
Open: $0.00
Previous Close: $232.40
52 Week Range: $115.94 - $234.68
Oustanding Shares: 300,237,694
Market Cap: 69,799,259,101
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 4 4 6
Moderate Buy 0 0 0 0
Hold 11 10 10 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.57 2.43 2.43 2.20
Latest Dividend: 0.05
Latest Dividend Yield: 0.09%
Dividend Ex-Date: 02/25/15
Price Earnings Ratio: 46.22
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
46.22 46.40 26.73
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.60% 82.58% 165.84%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.90 0.34 0.10
Net Income 54.60 0.63 0.18
EPS 54.60 0.67 0.18
Earnings for AGN:
EBITDA 2.49B
Revenue 7.24B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $1.79 $2.14 $8.58 $10.44
Number of Analysts 4 4 14 11
High Estimate $1.84 $2.20 $8.86 $11.65
Low Estimate $1.76 $2.11 $8.33 $9.91
Prior Year $1.18 $1.51 $6.65 $8.58
Growth Rate (Year over Year) 51.69% 41.89% 29.09% 21.67%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
It is no pipedream that the stock could trade to $240.
The two apparent failures are in fact opportunities.
Bearish
Jan 08, 2015 | 7:41 AM EST
AGN was downgraded from Buy to Neutral, BTIG said. Do not expect another takeover bid to materialize. 
Has the pharmaceutical company really changed its strategy?
An immense market rotation is happening.
This market provides a slew of reasons to buy right now.
I expect better from grown-up hedge fund managers.
In this market, negativity is rarely being rewarded.
The U.S. markets and economy are unique.
What this year-end flurry of deals highlights.

Columnist Conversations

I know right JC! It's that zombie that refuses to go away. (the company recently announced the closure of my ...
If you follow the oil markets this is a must read! http://www.platts.com/latest-news/oil/americas/hollyfrontie...
Many of the same 'talking heads' who thought rates would rise in 2014 now believe that rates will decline in 2...
I don't know, Soz, they cant kill this thing but I like your thoughts!

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.